GW
GW Pharma (Jazz)
Cambridge UKFounded 1998900 employees
Private CapbiotechAcquiredNeurology
Platform: Epidiolex CBD
Market Cap
N/A
All Drugs
3
Clinical Trials
8
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GW-1242 | GW-1242 | Phase 1/2 | 1 | Tau | PBCHuntington's | ||
| Capicagene | GW-9104 | Approved | 4 | TIM-3 | PsAAsthma | ||
| GW-7331 | GW-7331 | Phase 3 | 3 | PD-L1 | SMA |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (8)